-       Book 
- October 2018
- North America 
             -       Book 
- August 2018
- North America 
               -       Book 
- March 2018
- North America 
             -       Book 
- January 2018
- North America 
              -       Book 
- April 2017
- North America 
             -       Book 
- January 2017
- North America 
             -       Book 
- November 2016
- North America 
             -       Book 
- August 2016
- North America 
             -       Book 
- April 2016
- North America 
                      Otorhinolaryngology is a branch of medicine that focuses on the diagnosis and treatment of diseases and disorders of the ear, nose, and throat. It is an important field in drug discovery, as many of the drugs used to treat these conditions are developed through research and clinical trials. Otorhinolaryngology is a rapidly evolving field, with new treatments and therapies being developed to address a wide range of conditions.
Drug discovery in otorhinolaryngology is a complex process that involves    the identification of new compounds, the development of new drugs, and the testing of these drugs in clinical trials. The process is often lengthy and expensive, but the potential rewards are great. New drugs can provide relief to patients suffering from a variety of conditions, and can also lead to improved quality of life.
Some of the major companies in the otorhinolaryngology market include GlaxoSmithKline, Merck, Pfizer, Novartis, and Sanofi. These companies are involved in the development of new drugs and treatments for a variety of conditions, including allergies, hearing loss, and sinusitis. They are also involved in the research and development of new technologies and treatments for otorhinolaryngology. Show Less   Read more